This CME conference is guaranteed to provide a comprehensive update on GI and liver diseases from renowned faculty. The 1.5-day conference will have a strong focus on viral hepatitis, NAFLD/NASH, primary biliary cirrhosis, drug-induced liver injury, complications of portal hypertension, including hepatic encephalopathy and thrombocytopenia, hepatocellular carcinoma, GERD, chronic pancreatitis, fecal incontinence, and irritable bowel syndrome.